Clinical Trial: Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test

U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07307300) titled 'Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test' on Dec. 14.

Brief Summary: The goal of this clinical study is to learn how well a urine test called Xpert(R) Bladder Cancer Detect (Xpert BC-D) can help doctors assess the risk of bladder cancer in people with non-visible blood in their urine (microscopic hematuria). The main questions it aims to answer are:

* Can the Xpert BC-D test accurately identify people at higher risk for bladder cancer?

* Can combining the test results with other clinical information improve risk assessment compared to standard evaluatio...